Pain is a complex, multidimensional experience but often is measured as a unidimensional experience. This study aimed to separately assess the sensory and affective components of pain and identify their relations to important pain-related outcomes, particularly in terms of opioid misuse risk and emotion dysregulation among patients with chronic pain receiving treatment in Appalachia. Two hundred and twelve patients presenting to a multidisciplinary pain center completed the Difficulties in Emotion Regulation Scale (DERS-18), Screener and Opioid Assessment for Patients with Pain—Revised (SOAPP-R), and short-form McGill Pain Questionnaire (SF-MPQ). The sensory experience of pain was unrelated to emotion dysregulation (r = 0.06, ) and weakly related to opioid misuse risk (r = 0.182, ). In contrast, the affective experience of pain was moderately related to emotion dysregulation (r = 0.217, ) and strongly related to opioid misuse risk (r = 0.37, ). In addition, emotion dysregulation predicted variance in opioid misuse risk above and beyond the affective and sensory experiences of pain ((b = 0.693, ). The results suggest patients with a strong affective experience versus sensory experience of pain and challenges with emotion regulation may require a more comprehensive intervention to address these underlying components in order to reduce their risk of misusing opioid medications.

中文翻译：

---

疼痛经历及其与阿片类药物滥用风险和情绪失调的关系

疼痛是一种复杂的多维体验，但通常被视为单维体验。本研究旨在分别评估疼痛的感觉和情感成分，并确定它们与重要的疼痛相关结果的关系，特别是在阿巴拉契亚接受治疗的慢性疼痛患者的阿片类药物滥用风险和情绪失调方面。到多学科疼痛中心就诊的 212 名患者完成了情绪调节困难量表 (DERS-18)、疼痛患者筛查和阿片类药物评估 — 修订版 (SOAPP-R) 以及简短的麦吉尔疼痛问卷 (SF- MPQ）。疼痛的感觉体验与情绪失调无关（r  = 0.06，）并且与阿片类药物滥用风险弱相关（ r  = 0.182，）。相反，疼痛的情感体验与情绪失调呈中度相关（ r  = 0.217，）并且与阿片类药物滥用风险密切相关（ r  = 0.37，）。此外，情绪失调预测阿片类药物滥用风险的差异超出了疼痛的情感和感觉体验（（ b  = 0.693，）。结果表明，与疼痛和情绪调节挑战的感觉体验相比，具有强烈情感体验的患者可能需要更全面的干预来解决这些潜在因素，以降低滥用阿片类药物的风险。